Physician profile
Adam Hy
NPI 1982640413
$2,756.51
in general payments reported to CMS, 2019-2025
16 companies · $554 in 2025
The $554 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $14.66 · 2021: $384 · 2022: $302 · 2023: $752 · 2024: $498 · 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,804.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,018.70 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $271.79 | 2022-2024 | Arexvy, Shingrix |
| Amgen INC. | $259.95 | 2022-2025 | Evenity, Repatha, Repatha |
| Amarin Pharma, INC. | $224.76 | 2021 | |
| Lilly USA, LLC | $159.42 | 2020-2025 | Jardiance |
| Exact Sciences Corporation | $146.91 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $125.00 | 2023 | Xarelto |
| Esperion Therapeutics, INC. | $124.98 | 2022 | |
| Dexcom, INC. | $99.20 | 2023 | Dexcom G7 Gss (161) |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.76 | 2025 | Jardiance |
| Galderma Laboratories, L.P. | $65.71 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $46.74 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.33 | 2025 | |
| Eisai INC. | $32.40 | 2021 | |
| Fidia Pharma USA INC. | $21.24 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $16.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Hy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.